This case study is part of a series that explores pathways and important factors that contribute to the development and uptake of global health interventions - from proof of concept to scale-up.
A call to action for world leaders to convene a "Global Pandemic Response and Vaccination Summit" to create a coordinated, global response to the pandemic.
The COVID-19 vaccine manufacturing landscape is highly dynamic, both expanding and contracting almost daily. This issue brief is the first analysis of publicly available information about COVID vaccine manufacturing. Updated data available.
In this paper we analyze the impact of COVID-19 on maternal and child health services in Ethiopia and India at the outset of the pandemic from April to September 2020.
Tuberculosis (TB) is one of the leading causes of morbidity and mortality worldwide. Each year around 10 million people gets infected by TB and more than a million die from it. Drug-resistant TB is an increasing global health threat.
Sayana® Press (SP) is an easy-to-administer three-month injectable contraceptive (depot-medroxyprogesterone acetate, DMPA-SC) that has been hailed as a game changer in family planning.
Explore the pathways and important factors that contribute to the development and uptake of global health interventions - from proof of concept to scale-up.
Tuberculosis (TB) is considered one of the world’s most fatal infectious diseases, causing 4,109 deaths per day worldwide. Each year, over 1 million children become ill with TB, which accounts for 11% of the global burden.
Every year, an estimated 130,000 women die from postpartum hemorrhage—uncontrolled blood loss from mothers during birth. Another 2.6 million women are left disabled.